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Introduction
Mitogen-activated protein (MAP) kinases are ubiqui-
tous serine/threonine protein kinases that play an
important role in translating extracellular signals to
the nucleus (1, 2). Among these, p38 MAP kinase rep-
resents a human homologue of the Saccharomyces cere-
visiae HOG-1 gene product, a yeast MAP kinase
required for cellular osmoregulation (2, 3). p38 MAP
kinase is specifically regulated by changes in environ-
mental osmolarity by dual tyrosine/threonine phos-
phorylation (4) mediated by two MAP kinase kinases
(MEKs), MEK-3 and MEK-6 (5, 6). Members of the
p38 signaling complex are also activated in response
to lipopolysaccharides, proinflammatory cytokines,
and ultraviolet radiation (4, 7, 8). It has been shown
that p38 plays an important role in the cellular
response to osmotic changes: inhibition of p38 by
SB203580 prevents volume-sensitive induction of
multiple mRNAs (2, 9, 10).
In addition to the effects on p38, change in cell vol-
ume also appears to be an important stimulus for mod-
ulation of other members of the MAP kinase family,
including JNK and ERK (2, 9). Cell volume homeosta-
sis is mandatory for maintenance of cellular integrity,
but also represents a means of coupling changes in
membrane transport to other organ-specific functions.
An increase in cell volume, for example, appears to
serve as a signal regulating many liver functions, stim-
ulating protein synthesis, secretion, and gene expres-
sion. In addition to these physiologic roles, failure to
regulate cell volume has been implicated in liver cell
injury associated with alcohol, ischemia/reperfusion,
and organ preservation (11–13). Thus, one function of
MAP kinases may be to mediate volume-sensitive
changes in gene expression.
Recent studies suggest that p38 MAP kinase is consti-
tutively active in certain cells, and may also be capable of
regulating membrane transport through direct effects
on ion channels (14, 15). In hepatocytes, membrane Na+
permeability is low under basal conditions, but decreas-
es in cell volume stimulate an adaptive response that
involves Na+ influx through opening of nonselective
cation (NSC) channels. The resulting water influx leads
to restoration of cell volume toward basal values, a
process referred to as regulatory volume increase (RVI)
(16, 17). Since MAP kinases exhibit volume-sensitive
changes in activity, the purpose of these studies was to
assess the potential role of p38 and other MAP kinase
signaling pathways in volume-dependent changes in
membrane Na+ permeability. The findings suggest that
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In hepatocytes, Na+ influx through nonselective cation (NSC) channels represents a key point for reg-
ulation of cell volume. Under basal conditions, channels are closed, but both physiologic and patho-
logic stimuli lead to a large increase in Na+ and water influx. Since osmotic stimuli also activate mito-
gen-activated protein (MAP) kinase pathways, we have examined regulation of Na+ permeability and
cell volume by MAP kinases in an HTC liver cell model. Under isotonic conditions, there was consti-
tutive activity of p38 MAP kinase that was selectively inhibited by SB203580. Decreases in cell volume
caused by hypertonic exposure had no effect on p38, but increases in cell volume caused by hypotonic
exposure increased p38 activity tenfold. Na+ currents were small when cells were in isotonic media
but could be increased by inhibiting constitutive p38 MAP kinase, thereby increasing cell volume. To
evaluate the potential inhibitory role of p38 more directly, cells were dialyzed with recombinant p38α
and its upstream activator, MEK-6, which substantially inhibited volume-sensitive currents. These
findings indicate that constitutive p38 activity contributes to the low Na+ permeability necessary for
maintenance of cell volume, and that recombinant p38 negatively modulates the set point for vol-
ume-sensitive channel opening. Thus, functional interactions between p38 MAP kinase and ion chan-
nels may represent an important target for modifying volume-sensitive liver functions.
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constitutive activity of p38 MAP kinase plays an essen-
tial role in maintenance of cell volume through tonic
inhibition of Na+-permeable ion channels.
Methods
Cell culture. All studies were performed in HTC cells, a
model rat hepatoma cell line that expresses ion channels
and signaling pathways similar to those found in pri-
mary rat hepatocytes (18, 19). Decreases in HTC cell
volume, stimulated by exposure to hypertonic buffer or
oxidative stress, are followed by opening of Na+-perme-
able channels in the plasma membrane (20). Cells were
passaged at weekly intervals and maintained in MEM
containing HCO3– (Invitrogen, Grand Island, New York,
USA) supplemented with 10% heat-inactivated FBS, L-
glutamine (2 mM), penicillin (100 IU/ml), and strepto-
mycin (100 µg/ml) as previously described (21).
Measurement of Na+ currents. Membrane Na+ currents
were measured using whole-cell patch-clamp tech-
niques. Cells on a cover slip were mounted in a cham-
ber (volume ∼400 µl) and perfused at 4–5 ml/min with
a standard extracellular solution containing (in mM):
140 NaCl, 4 KCl, 1 CaCl2, 2 MgCl2, 1 KH2PO4, 10 glu-
cose, and 10 HEPES/NaOH (pH ∼7.40). The standard
intracellular (pipette) solution for whole-cell record-
ings contained (in mM): 130 KCl, 10 NaCl, 2 MgCl2, 10
HEPES/KOH, 0.5 CaCl2, and 1 EGTA (pH 7.3), corre-
sponding to a free [Ca2+] of approximately 100 nM (22).
Patch pipettes were pulled from 7052 glass (Garner
Glass Co., Claremont, California, USA) and had a
resistance of 3–10 MΩ. Recordings were made with an
Axopatch ID amplifier (Axon Instruments Inc., Foster
City, California, USA), and were digitized (1 kHz) for
storage on a computer and analyzed using pCLAMP
version 6.0 (Axon Instruments Inc.) as previously
described (23, 24). Three voltage protocols were used:
(a) holding potential –40 mV, with 200-ms steps to 0
mV and –80 mV at 10-second intervals (for real-time
tracings); (b) holding potential –40 mV, with 400-ms
steps from –100 mV to +100 mV in 20-mV increments;
and (c) holding potential –40 mV and voltage ramp
from –100 mV to +100 mV over 200 ms. Current-volt-
age (I-V) relationships were generated from the “step”
or “ramp” protocols as indicated. Pipette voltages are
referred to the bath. In the whole-cell configuration,
pipette voltage corresponds to the membrane poten-
tial, and upward deflections of the current trace indi-
cate outward membrane current. Results are compared
with control studies measured on the same day to min-
imize any effects of day-to-day variability, and are
reported as current density (pA/pF) to normalize dif-
ferences in cell size (21).
Cell size measurements. Mean cell volume was measured
in cell suspensions by electronic cell sizing with a Coul-
ter Multisizer and AccuComp software version 1.19
(Coulter International Inc., Hialeah, Florida, USA)
using an aperture of 100 µm, as previously described
(25). Cells in subconfluent culture were harvested with
0.05% trypsin, suspended in cell culture media, cen-
trifuged for 1 minute at approximately 1,000 g, resus-
pended in 3 ml of isotonic buffer, and incubated with
gentle agitation for 30–45 minutes. Aliquots (∼500 µl)
of cell suspension were added to 20 ml of isotonic or
hypertonic (40% increase in NaCl or 100 mM sucrose,
∼395 mOsm) buffer. Measurements of approximately
20,000 cells were compared with basal values (time 0)
at specified timepoints after exposure to isotonic or
hypertonic buffer. Changes in value are expressed as
relative volume normalized to the basal value. Experi-
mental reagents were added as indicated.
MAP kinase activity. Measurements of MAP kinase activ-
ity were performed as previously reported, with minor
modifications (26, 27). Cells were exposed to hypotonic
(100 mOsm) or hypertonic (∼500 mOsm) treatment for
5 minutes, then immediately homogenized in ice-cold
lysis buffer (50 mM β-glycerophosphate (pH 7.2), 0.5%
Triton X-100, 0.1 mM sodium vanadate, 2 mM MgCl2, 1
mM EGTA, 1 mM DTT, 2 µg/ml leupeptin, and 4 µg/ml
aprotinin). The lysate was centrifuged at 4°C for 10 min-
utes at 10,000 g, and supernatants were adjusted to
100–200 µg protein in 0.5 ml.
For measurement of JNK activity, 100 µl of 10%
GST–c-Jun agarose beads was added. After 2 hours of
rocking incubation at 4°C, the adsorbed proteins were
washed three times in lysis buffer and resuspended in
40 µl β-glycerophosphate (50 mM, pH 7.2), 0.1 mM
sodium vanadate, 10 mM MgCl2, and 100 µM
γ[32P]ATP (5,000 cpm/pmol). The reactions were incu-
bated for 20 minutes at 30°C, then stopped by the
addition of hot SDS sample buffer. The lysates were
heated in a boiling water bath for 5 minutes and sub-
sequently subjected to SDS-PAGE on a 10% polyacry-
lamide gel, followed by autoradiography. The bands
corresponding to phosphorylated c-Jun were excised
and counted in a liquid scintillation counter.
For measurement of ERK activity, 2.5 µl each of anti-
sera against ERK1 and ERK2 (Sc-94 and Sc-93 rabbit
polyclonal antisera; Santa Cruz Biotechnology Inc.,
Santa Cruz, California, USA) was added, along with
100 µl 10% protein A–Sepharose (Pharmacia Biotech
Inc., Piscataway, New Jersey, USA). After 2 hours of
rocking incubation at 4°C, the adsorbed proteins were
washed three times in lysis buffer and resuspended in
40 µl β-glycerophosphate (50 mM, pH 7.2), 0.1 mM
sodium vanadate, 10 mM MgCl2, 100 µM γ[32P]ATP
(5,000 cpm/pmol), 50 µg/ml IP-20 (TTYADFIASGRT-
GRRNAIHD), and 200 µM EGF-R peptide (RRELVE-
PLTPSGEAPQALLR). The reactions were incubated for
20 minutes at 30°C, then stopped by the addition of 10
µl of 25% trichloroacetic acid. EGF-R peptide phos-
phorylation was assessed by phosphocellulose filter
binding as described (28). PD98059 (100 µM), an
inhibitor of MEK-1 (the upstream activator of ERK),
was added in selected experiments.
For measurement of p38 MAP kinase activity, cul-
tured cells were homogenized as above, and lysates were
heated in a boiling water bath after addition of SDS
sample buffer. Then 50 µg of protein was loaded per
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lane on either a 10% or a 12.5% polyacrylamide gel and
subjected to SDS-PAGE. Proteins were transferred to
either Immobilon or NitroPlus (Micron Separations
Inc., Westboro, Massachusetts, USA), and the blot was
blocked with 5% BSA, Fraction V (AMRESCO Inc.,
Solon, Ohio, USA) in Tris-buffered saline (pH 8) plus
0.1% Tween 80 for 2 hours at room temperature. Anti-
sera incubation was done at 4°C for 16 hours in 5%
BSA/Tween 80/TBS, after which the membrane was
washed with Tween 80/TBS. Secondary antisera con-
jugated to horseradish peroxidase were incubated with
the membrane for 2 hours at room temperature in 5%
BSA/Tween 80/TBS, followed by washes as above and
incubation with chemiluminescent substrate. An anti-
body specific for the activated (phosphorylated at Thr-
180 and Tyr-182) form of p38 MAP kinase, and a con-
trol antibody that does not distinguish between
phospho- and dephosphorylated p38 MAP kinase, were
obtained from New England Biolabs Inc. (Beverly,
Massachusetts, USA). Intensity of bands on Western
blot films was determined by scanning with a video
image scanner and digitizing software.
Reagents. PD98059 (100 µM; Parke-Davis, Ann Arbor,
Michigan, USA) was used as an inhibitor of MEK-1, the
upstream activator of ERK (29). SB203580 (500 nM to 1
µM; Calbiochem-Novabiochem, La Jolla, California,
USA) was used as an inhibitor of p38 (30, 31). In separate
patch-clamp studies, recombinant p38α and MEK-6
were delivered to the cell interior by inclusion in the
patch pipette (32). EGTA (5 mM) and amiloride (100
µM) were used in selected patch-clamp experiments.
Statistics. Results are presented as mean ± SEM, with
n representing the number of cells used for patch-
clamp studies and the number of culture plates or rep-
etitions for other assays. The Student paired or
unpaired t test was used to assess statistical signifi-
cance as indicated, and P values < 0.05 were considered
to be statistically significant.
Results
Cell volume increases are mediated by channel-mediated Na+
influx. Exposure of cells to hypertonic buffer (40%
increase in NaCl, ∼395 mOsm) caused a rapid initial
decrease in relative volume to 0.85 ± 0.01 (n = 6, 
P < 0.001 compared with isotonic conditions) within 3
minutes. The decrease was followed by gradual recov-
ery toward basal values (RVI) despite continued expo-
sure to hypertonic buffer (0.94 ± 0.01 at 30 minutes;
Figure 1). Volume recovery was inhibited (0.79 ± 0.02 at
30 minutes, P < 0.001) when Na+ in the bath solution
was replaced with the impermeant ion Tris+, indicating
that volume recovery is mediated by Na+ influx.
To determine if Na+ influx is mediated by a conductive
pathway, parallel whole-cell patch-clamp studies were
performed. With the standard bath and pipette solutions,
the reversal potential for Na+ ions (ENa+) is +66 mV, and
the reversal potential for cations (Ecat) is 0 mV. Conse-
quently, the opening of a Na+-selective conductance
would result in inward currents at both 0 mV and –80
mV, and the opening of an NSC conductance would
result in inward currents at –80 mV but not at 0 mV (Ecat).
Under basal conditions, currents were small (less
than –3.0 ± 1.1 pA/pF at –80 mV). Exposure to hyper-
tonic buffer (20 mM sucrose, ∼320 mOsm) resulted in
activation of inward currents within 2–3 minutes (rep-
resentative trace shown in Figure 2a), increasing cur-
rent density more than 30-fold, from –2.1 ± 0.3 pA/pF
to –69.5 ± 11.2 pA/pF at –80 mV (P < 0.001, n = 20).
Hypertonic-induced currents displayed a linear I-V
relationship between –120 and +100 mV, and a rever-
sal potential near 0 mV (Figure 2b). Because currents
at –80 mV could be due to either Cl– or NSC conduc-
tance, several additional studies were performed to
determine the permeability of the hypertonically stim-
ulated conductance. First, the amplitude and reversal
potential were unaffected by substitution of bath Na+
with K+ (–58.6 ± 13.1 pA/pF, n = 4; Figure 2b). Second,
the Cl– channel blocker 5-nitro-2-(3-phenylpropy-
lamine)benzoic acid (NPPB) had little effect on the
magnitude of the currents at –80 mV (–55.4 ± 14.2, 
n = 4). Third, partial replacement of extracellular Na+
with Tris+ reduced inward currents and caused a neg-
ative shift in the reversal potential (Figure 2, b–d).
Decreasing extracellular [Na+] to 40 mM decreased the
magnitude of the inward currents (–160 ± 35.8 pA, 
n = 5, P < 0.001; Figure 2c) measured at –80 mV and
shifted the reversal potential to –26.6 ± 2.3 mV (Figure
2d) compared with control (–781.1 ± 71.7 inward cur-
rent pA, n = 9; reversal potential +0.5 ± 0.01 mV).
Decreasing extracellular [Na+] to 20 mM decreased the
magnitude of inward currents further (to –53.4 ± 6.17
pA, n = 4, P < 0.001), and shifted the reversal potential
in a more negative direction (to –41.3 ± 3.8 mV). It
should be noted that while substitution with Tris+
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Figure 1
Cell volume recovery is Na+ dependent. HTC cell suspensions were
exposed to hypertonic buffer (40% increase in NaCl, ∼395 mOsm)
at time 0, and cell volume (20,000 cells for each timepoint) was
measured with a Coulter Multisizer. Hypertonic exposure resulted
in a rapid initial decrease in cell volume, followed by gradual recov-
ery toward basal values. When Na+ in the buffer solution was
replaced with the impermeant cation Tris+, volume recovery was
inhibited. Values represent mean ± SEM for four trials, with 20,000
cells for each timepoint.
decreased inward currents as expected for a cation-
selective channel, Tris+ also decreased the magnitude
of outward currents measured at positive voltage
potentials (Figure 2b), suggesting that Tris+ may also
display nonspecific channel-blocking properties. The
shift in reversal potential at the different extracellular
cation concentrations is shown in Figure 2d. As
shown, the findings are consistent with the reversal
potential predicted by the Goldman-Hodgkin-Katz
equation for a primary cation conductance (dotted
line). The predicted reversal potential for a primary Cl–
conductance is shown for comparison. Taken togeth-
er, these findings are consistent with volume-sensitive
Na+ influx through opening of an NSC channel with
approximately equal Na+ and K+ permeability.
HTC cells have previously been shown to express an
NSC conductance that displays Ca2+-dependent open-
ing (18, 20). To determine if this hypertonically stimu-
lated cation conductance is Ca2+ dependent, separate
experiments were performed with low intracellular
[Ca2+]. Increasing EGTA (5 mM, no added Ca2+) in the
pipette solution inhibited current activation by hyper-
tonic exposure (–8.1 ± 2.8 pA/pF, n = 5, P < 0.001; see
Figure 5, solid bars) compared with control conditions
(free [Ca2+] ∼100 nM, –69.5 ± 11.2 pA/pF, n = 20). Pre-
vious studies of primary rat hepatocytes indicated that
RVI following hypertonic exposure is mediated by an
amiloride-sensitive Na+ conductance (16, 33). To deter-
mine whether the hypertonically stimulated conduc-
tance in HTC cells displays similar properties, studies
were performed in the presence or absence of the Na+
channel inhibitor amiloride (100 µM). Amiloride inhib-
ited hypertonically stimulated (50 mM sucrose) cur-
rents by approximately 68% (–37.7 ± 5.8 pA/pF, n = 5, 
P < 0.01) compared with control (–116.9 ± 17.8 pA/pF,
n = 9; see Figure 5, solid bars). 
Osmolarity-sensitive changes in MAP kinase activity. To eval-
uate the effects of HTC cell size on MAP kinase activity,
cells were exposed to hypertonic (500 mOsm) or hypo-
tonic (100 mOsm) conditions for 5 minutes, and kinase
activity was assessed. Representative measurements of
p38 MAP kinase are shown in Figure 3a; summary data
for all kinases are shown in Figure 3b. Under isotonic
conditions, there was detectable constitutive activity of
p38, JNK, and ERK kinases. Decreases in cell volume
caused by hypertonic exposure increase in both ERK
(fivefold) and JNK (fourfold) activity, but had little effect
on p38 MAP kinase activity. In separate studies, the
MEK-1 inhibitor PD98059 (100 µM) inhibited both
basal (by 65.5% ± 10.1%) and hypertonically induced (by
86.1% ± 15.5%) ERK activity (data not shown).
In contrast, increases in cell volume caused by hypo-
tonic exposure resulted in a large increase in p38 MAP
kinase activity (tenfold), but had little effect on ERK or
JNK activity compared with isotonic conditions. The
putative p38 MAP kinase inhibitor SB203580 (1 µM)
did not effect ERK or JNK activity, but completely
inhibited both constitutive and volume-sensitive p38
MAP kinase activity (Figure 3). These studies demon-
strate that (a) there is constitutive ERK, JNK, and p38
MAP kinase activity under basal (isotonic) conditions;
(b) increases in cell volume (hypotonic exposure)
increase p38 activity; and (c) there is differential regu-
lation of p38 MAP kinase activity versus ERK and JNK
activity in response to changes in HTC cell volume.
Na+ permeability is not influenced by ERK activity. Given
the large increase in ERK activity with hypertonic expo-
sure, the potential role of ERK in NSC channel regula-
tion was evaluated. If ERK modulates volume-sensitive
membrane Na+ permeability through MEK-1 activa-
tion, inhibition of MEK-1 would be expected to prevent
channel opening. To test this hypothesis, whole-cell
patch-clamp experiments were performed in the pres-
ence or absence of PD98059 (100 µM), an inhibitor of
MEK-1. In control cells, exposure to hypertonic buffer
(50 mM sucrose, ∼350 mOsm) resulted in characteris-
tic increases in Na+ permeability (–86.1 ± 14.2 pA/pF, 
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Figure 2
Hypertonic exposure activates NSC currents. (a) Representative
whole-cell recording. Currents at –80 mV (downward deflection of the
current tracing) correspond to INa+ (see Methods). Hypertonic expo-
sure (sucrose 20 mM, ∼320 mOsm) resulted in activation of inward
currents (top tracing). A voltage-step protocol (test potentials
between –100 mV and +100 mV in 20-mV increments) was used to
measure basal and hypertonic-induced currents (bottom tracings).
(b) I-V relationship of whole-cell currents. Currents induced by hyper-
tonic exposure were measured utilizing a voltage-ramp protocol (–100
mV to +100 mV over 200 ms). Hypertonicity increased current ampli-
tude with either Na+ or K+ as the primary extracellular cation, charac-
terized by reversal near 0 mV. When Na+ in the extracellular solution
was partially replaced with the impermeant cation Tris+ (final [Na+],
40 mM), there was a significant decrease in inward current amplitude,
and a shift in reversal potential to –26.6 ± 2.3 mV (n = 4), as expect-
ed for a cation-selective channel. (c) Decreasing [Na+] in the extra-
cellular solution by partial replacement with the impermeant cation
Tris+ resulted in a significant decrease in the magnitude of the inward
currents measured at –80 mV. (d) Decreasing [Na+ + K+], by replace-
ment with Tris+, resulted in a shift in reversal potential consistent with
the predicted reversal potential for a cation-selective conductance
(shown by dotted line). The expected reversal potential for a primary
Cl– conductance is shown by the dotted line at top.
n = 6), and the response was unchanged in the presence
of PD98059 (–68.9 ± 9.3 pA/pF, n = 5, data not shown).
Thus, volume-sensitive increases in ERK activity are not
likely to be involved in the regulation of Na+ influx.
Inhibition of p38 increases membrane Na+ permeability.
Since there did not appear to be a direct effect of ERK
on channel regulation, the alternative possibility that
p38 MAP kinase has an inhibitory role in channel regu-
lation was explored by measuring membrane Na+ per-
meability under basal conditions and during inhibition
of p38 (Figure 4). Whole-cell currents were small in con-
trol cells (–2.1 ± 0.3 pA/pF, n = 15). However, exposure
to the p38 MAP kinase inhibitor SB203580 (500 nM)
was followed by an increase in membrane Na+ perme-
ability in the absence of a volume challenge (–62.7 ± 8.1
pA/pF, n = 15, P < 0.001; Figure 4, a–c). The SB203580-
activated current appeared identical to that activated by
hypertonic exposure, with a linear I-V relationship, and
reversal near 0 mV (Figure 4, a and d). Substitution of
extracellular Na+ with K+ did not affect current ampli-
tude (–69.4 ± 12.5 pA/pF, n = 4); nor did exposure to the
Cl– channel inhibitor NPPB (–43.6 ± 10.8 pA/pF, n = 4,
P > 0.05). However, partial substitution of bath Na+ with
Tris+ significantly inhibited inward current amplitude
(measured at –80 mV) and shifted the reversal potential
in a negative direction (inward current, –340.1 ± 56.5
pA, and reversal potential, –25.3 ± 2.6 mV, at [Na+] = 40
mM, n = 5, P < 0.001; and inward current, –168.2 ± 14.8
pA, and reversal potential, –40.5 ± 4.2 mV at [Na+] = 20
mM, n = 4, P < 0.001) compared with control ([Na+] =
140 mM, –941.2 ± 84.5 pA inward current, and 0 ± 0.1
mV reverse potential, n = 9).
The SB203580-activated currents also exhibited simi-
lar regulatory properties, in that (a) inclusion of EGTA (5
mmol/l, no added Ca2+) in the patch pipette abolished
the response (–8.5 ± 2.1 pA/pF, n = 5, P < 0.01; Figure 5,
open bars), and (b) exposure to amiloride (100 µM) inhib-
ited currents by approximately 61% (–38.36 ± 10.8 pA/pF,
n = 4) compared with control cells (–99.54 ± 6.55 pA/pF,
n = 10, P < 0.001; Figure 5, open bars). Lastly, the hyper-
tonic-induced and SB203580-activated currents were not
additive. When currents were first activated by hyperton-
ic exposure (50 mM sucrose, –69.5 ± 11.2 pA/pF, n = 6)
there was no further increase caused by exposure to
SB203580 (500 nM, –70.73 ± 7.65 pA/pF, n = 6; Figure 4,
a and c). Taken together, these findings indicate that cur-
rents activated by SB203580 are not distinguishable from
currents activated by hypertonic exposure, and suggest
an important regulatory role for p38 MAP kinase in inhi-
bition of volume-sensitive Na+ permeability.
Inhibition of p38 activity increases cell size. Since inhibi-
tion of p38 increases membrane Na+ permeability, the
resulting influx of Na+ would be expected to increase
cell volume. To assess this directly, cell volume was
measured in the presence or absence of p38 inhibition
(Figure 6). Compared with control, acute inhibition
of p38 with SB203580 (500 nM) resulted in a rapid
initial increase in cell size (5.8% ± 0.1%, n = 5, P < 0.01),
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Figure 3
Osmolarity-sensitive changes in MAP kinase activity. HTC cells were
exposed to isotonic (∼300 mOsm), hypotonic (∼100 mOsm), or
hypertonic (∼500 mOsm) buffer solutions for 5 minutes, then imme-
diately homogenized in lysis buffer. (a) Cell lysates were subjected to
SDS-PAGE and Western blot analysis with either an antibody specif-
ic for the activated (phosphorylated at Thr-180 and Tyr-182) form
of p38 (phospho-p38) or a control antibody that does not distin-
guish between phospho- and dephosphorylated p38 MAP kinase
(total p38). Constitutive phospho-p38 activity was observed under
isotonic conditions; values increased with hypotonic exposure. Activ-
ity was inhibited by the p38 inhibitor SB203580 (1 µM), but not by
the tyrosine kinase inhibitor genistein (10 µM). None of the various
exposures resulted in changes in total p38. (b) Average MAP kinase
activity in response to osmotic changes performed as described in
Methods. Under isotonic conditions, there was constitutive activity
of p38, JNK, and ERK kinases. Hypertonic exposure stimulated a
large increase in both ERK (fivefold) and JNK (fourfold) activity, but
had little effect on p38 MAP kinase activity. In contrast, hypotonic
exposure resulted in a large increase in p38 MAP kinase activity (ten-
fold), but had little effect on ERK or JNK activity compared with iso-
tonic conditions. The putative p38 MAP kinase inhibitor SB203580
did not affect ERK or JNK activity, but completely inhibited consti-
tutive p38 MAP kinase activity.
reaching a maximum at 5 minutes. This was followed
by a gradual return to basal values by 30 minutes.
This gradual decrease in cell size likely represents an
adaptive response to cell swelling, as previously
described in these and other cell types (25, 34). Thus,
constitutive activity of p38 serves an important role
in the maintenance of cell volume and membrane Na+
permeability under isotonic conditions.
Intracellular dialysis with purified p38 MAP kinase inhibits
channel opening. Since kinase inhibition can have unan-
ticipated effects on other regulatory pathways, an
alternate strategy was used to assess the relationship
between p38 MAP kinase and Na+ permeability. p38α
is activated by dual phosphorylation of adjacent tyro-
sine and threonine residues by the upstream MAP
kinase kinase, MEK-6 (35–37). To determine if activat-
ed p38α MAP kinase inhibits channel function, the
purified kinases p38α (5 µg/ml) and MEK-6 (5 µg/ml)
were delivered, individually or together, to the cell inte-
rior by inclusion in the patch pipette. There was no
effect by p38α and MEK-6 together on basal currents
measured under isotonic conditions (Figure 7, a and b).
In control cells dialyzed with heat-inactivated (100°C,
30 minutes) p38α and MEK-6, hypertonic exposure (20
mM sucrose, ∼320 mOsm; Figure 7) resulted in char-
acteristic current activation (–62.5 ± 18.7 pA/pF, n = 5).
Dialysis with either p38α or MEK-6 individually result-
ed in partial inhibition (–40.1 ± 8.2 pA/pF and 
–46.8 ± 10.3 pA/pF, n = 4, respectively; Figure 7, values
not statistically significant compared with control).
However, dialysis with p38α and MEK-6 together
resulted in significant inhibition of the response to
hypertonic exposure (–10.4 ± 3.5 pA/pF, n = 6, P < 0.01;
Figure 7, a and b). To assess whether the inhibitory
effects of recombinant p38α + MEK-6 were detected
over a broader range of osmotic challenge, cells were
exposed to graded increases in osmolarity (Figure 7c).
Under control conditions, the current amplitude
increased with increasing transmembrane osmolar gra-
dients. In the presence of intracellular p38α + MEK-6,
there was significant inhibition of current amplitude
at lower transmembrane osmolar gradients (10 mM
and 20 mM sucrose, P < 0.01). The inhibitory effect of
p38α + MEK-6 was overcome at higher transmembrane
osmolar gradients (50 mM sucrose, P > 0.05 compared
with control at 50 mM sucrose).
Discussion
Environmental signals such as ultraviolet radiation,
heat shock, and osmotic stress cause p38 MAP kinase
activation in several cell types (4, 7, 8). While many of
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Figure 4
Inhibition of p38 MAP kinase increases membrane Na+ permeability.
Whole-cell currents were measured under basal conditions and dur-
ing exposure to the p38 inhibitor SB203580 (500 nM). (a) Represen-
tative whole-cell recordings. Currents at –80 mV (downward deflec-
tion of the current trace) correspond to INa+. Under basal conditions,
currents were small (first tracing). Exposure to SB203580 stimulated
an increase in currents (second tracing) with properties similar to
those activated by hypertonic exposure (20 mM sucrose, third trac-
ing). Exposure to SB203580 did not further increase current magni-
tude after cells were first exposed to hypertonicity (50 mM sucrose,
∼350 mOsm) to maximally activate currents (fourth tracing). (b) Volt-
age-step protocol (as described in Figure 2a) demonstrating currents
under control conditions and following exposure to SB203580 (500
nM). (c) Cumulative data recorded as average current density at –80
mV. Both SB203580 (500 nM) and hypertonicity (50 mM sucrose)
resulted in large increases in inward currents. The responses were not
additive. (d) I-V relationship of whole-cell currents measured under
basal conditions and during exposure to SB203580. With Na+ as the
primary extracellular cation, currents were characterized by a nearly
linear I-V relationship and reversal near 0 mV. Partial replacement of
Na+ with Tris+ (final [Na+] = 20 mM) decreased inward currents and
shifted the reversal potential to –40.5 ± 4.2 mV, as expected for a
cation-selective conductance.
Figure 5
Comparison of hypertonic- and SB203580-induced currents. Average
current density for currents activated by hypertonic exposure (20 mM
sucrose) or SB203580 (500 nM) was measured at –80 mV. Both hyper-
tonic- and SB203580-induced currents were inhibited by inclusion of
EGTA (5 mM, no added Ca2+) in the patch pipette solution, and by
amiloride (100 µM) in the extracellular solution (P < 0.01).
the physiologic effects of p38 are mediated by tran-
scriptional regulation, there is increasing evidence that
p38 can interact with and modulate other cytoplasmic
and membrane proteins in a phosphorylation-depend-
ent manner. In these studies of HTC cells, observa-
tions using a variety of techniques support a broader
role for p38 MAP kinase as an early and important sig-
nal in coordinating changes in cell volume and mem-
brane Na+ permeability.
The principal findings of these studies are that (a)
there is constitutive activity of p38 MAP kinase under
basal (isotonic) conditions; (b) inhibition of constitu-
tive p38 MAP kinase results in increased membrane
Na+ permeability and increases in cell volume; (c) intra-
cellular dialysis with purified p38α, and its upstream
activator MEK-6, inhibits volume-sensitive channel
opening; and (d) exposure to hypotonicity to increase
cell volume results in large increases in p38 activity.
Collectively, these findings suggest that p38 MAP
kinase plays an important regulatory role governing
membrane Na+ permeability and cell volume regula-
tion through inhibitory effects on NSC channels.
Previous biophysical studies have identified NSC
channels in liver cells that are regulated in part by
cytosolic [Ca2+] (18, 20). While channel proteins are
abundant, with approximately 2,000 channels/cell,
they are generally closed under basal conditions. Chan-
nels open in response to vasopressin or other agents
known to mobilize Ca2+ (23), and in response to cell
shrinkage induced by osmotic (17) or oxidative stress
(20). The resulting influx of Na+ favors water move-
ment into the cell and restoration of cell volume
toward basal values. Interestingly, p38 MAP kinase is
known to be constitutively active in hepatocytes, and
its activity is selectively decreased during oxidative
stress (38), consistent with a potential role as an
inhibitor of Na+ influx.
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Figure 6
Inhibition of p38 increases cell volume. Cell volume was measured in
the presence or absence of p38 inhibitor using a Coulter Multisizer.
Compared with control, acute inhibition of p38 with SB203580 (500
nM) resulted in a rapid initial increase in cell size (5.8 ± 0.1%, n = 5,
P < 0.01), reaching a maximum at 5 minutes. This was followed by a
gradual return to basal values by 30 minutes.
Figure 7
Intracellular dialysis with recombinant p38 MAP kinase protein
inhibits volume-sensitive current activation. Under whole-cell patch-
clamp conditions, the recombinant kinases p38α (5 µg/ml) and
MEK-6 (5 µg/ml) were delivered, individually or together, to the cell
interior by inclusion in the patch pipette, and cells were then exposed
to hypertonic buffer (20 mM sucrose, ∼320 mOsm). (a) Whole-cell
currents measured using the voltage-step protocol (as described in
Figure 2a). Currents were small with intracellular dialysis of p38α and
MEK-6 under isotonic conditions (top tracing). However, p38α and
MEK-6 significantly inhibit the amplitude of hypertonic-induced cur-
rents (bottom tracing) as compared with control (middle tracing).
(b) Cumulative data expressed as average current density at –80 mV.
Control cells, dialyzed with heat-inactivated p38α and MEK-6,
demonstrated characteristic current activation. Dialysis with either
p38α or MEK-6 individually resulted in partial inhibition, which was
not statistically significant compared with control. However, dialysis
with p38α and MEK-6 together resulted in significant current inhi-
bition. There was no effect of p38α and MEK-6 on basal (isotonic)
currents. (c) Under control conditions, current density increased with
increasing transmembrane osmolar gradients. In the presence of
intracellular p38α + MEK-6, there was significant inhibition of cur-
rent amplitude at lower transmembrane osmolar gradients (5–20
mM sucrose). However, this inhibitory effect was overcome at high-
er transmembrane osmolar gradients (50 mM sucrose). *P < 0.01.
These studies provide further evidence that NSC
channels are crucial to the maintenance of cell volume
and RVI in hepatocytes. The conductance is character-
ized by equal permeability for Na+ and K+ and a linear
I-V relationship, and shows no time dependence. Par-
tial substitution of extracellular Na+ with Tris+ causes
a decrease in inward currents and a negative shift in
reversal potential, as anticipated for an NSC conduc-
tance. It should be noted, however, that a slight
decrease in the amplitude of outward currents was also
observed with Tris+ substitution. The possibility that
Tris+ is also a partial channel blocker, or has other non-
specific effects on cell volume, intracellular pH, or
other parameters that may affect channel open proba-
bility cannot be excluded.
The partial inhibition of volume-sensitive conduc-
tance by amiloride is consistent with previous studies
of rat hepatocytes (16). Previous reports in other cell
types have demonstrated variable effects of amiloride
on NSC currents (39–42). This variability may reflect
different channel types; the molecular identity of NSC
channels in liver cells has not been defined. The basic
biophysical properties of the NSC channels described
here appear similar to cyclic nucleotide–gated channels
described in other cell types (43, 44) that demonstrate
amiloride sensitivity (45–47). The finding that
amiloride only partially inhibits NSC conductance has
several potential explanations. First, amiloride sensi-
tivity may be modulated by [Ca2+] (39, 48), mechanical
stress (49), or other factors. Alternatively, more than
one Na+ channel type may contribute to volume-regu-
lated Na+ influx. In fact, the epithelial Na+ channel
(ENaC), which is also inhibited by amiloride, has
recently been implicated in volume-stimulated Na+
influx in rat hepatocytes (33). However, the NSC con-
ductance of HTC cells does not exhibit the pore or reg-
ulatory properties anticipated for ENaC. Thus, it will
be important to define the molecular mechanisms
responsible for volume-sensitive Na+ influx, and assess
the specific regulatory pathways involved for each.
Two primary observations support a role for consti-
tutive p38 MAP kinase activity in the regulation of cell
volume. First, under isotonic conditions, inhibition of
p38 with SB203580 increased membrane Na+ perme-
ability. Currents activated by SB203580 demonstrated
biophysical properties that were identical to those of
currents activated by hypertonic exposure, including a
linear I-V relationship, equal permeability to Na+ and
K+, Ca2+-dependent regulation, and amiloride sensitiv-
ity. Second, exposure to SB203580 was followed by an
increase in cell volume (∼6%), consistent with an impor-
tant role for p38 MAP kinase in the maintenance of
resting cell volume under isotonic conditions.
While the inhibitory effects of SB203580 are
detectable at low micromolar concentrations and
appear to be specific for p38 (50, 51), it is acknowl-
edged that SB203580 could have unanticipated effects
on other signaling pathways. Consequently, an alter-
native strategy was used to evaluate the roles of recom-
binant p38α and the upstream MAP kinase kinase
MEK-6 on channel regulation. Intracellular delivery of
these kinases inhibited volume-sensitive current acti-
vation. Indeed, intracellular delivery of active p38α
resulted in a large shift in the activation curve, so that
much higher degrees of hypertonicity were required
before channel opening was observed. Dialysis with
either p38α or MEK-6 alone resulted in only partial
inhibition of currents, and dialysis with heat-inactivat-
ed p38α had no effect. Thus, p38α, when present with
its specific activator, is capable of channel inhibition.
The partial effect observed with either p38α or MEK-6
alone may be related to activation of these proteins by
endogenous cellular kinases. It is important to note
that at higher degrees of hypertonicity (50 mM
sucrose), NSC conductance could be activated even in
the presence of p38α and MEK-6. Thus, the inhibitory
effect of p38 MAP kinase can be overcome by positive
regulatory signals. In fact, there was no observable
decrease in p38 activity with hypertonic exposure. Con-
sequently, it will be important to define the additional
regulatory pathways (regulatory proteins, cytoskeletal
elements, insertion of new channels into the mem-
brane, etc.) that are able to overcome the inhibitory
effects of p38 and stimulate channel opening during
hypertonic conditions.
The effects of p38 MAP kinase on membrane Na+ per-
meability have several implications. First, while p38 has
previously been shown to be an important regulator of
transcription, these effects on Na+ permeability imply
that p38 MAP kinase has plasma membrane targets as
well. Indeed, recent evidence suggests that p38 may
modulate the Na+/H+ exchanger (NHE-1) in vascular
smooth muscle cells (15), Ca2+-activated, voltage-gated
channels in neuronal cells (14), and acid secretion from
gastric parietal cells (52). In all cases, p38 appears to
have an inhibitory role, as observed here. However,
whether p38 regulates channel function through a
direct phosphorylation event or through downstream
kinase pathways is yet to be determined. Second, while
MAP kinase pathways were thought to mediate the
effects of growth factors and hormones on sustained
cellular events such as proliferation and differentiation,
recent evidence has now emerged that MAP kinase path-
ways can also be activated by heterotrimeric G proteins
(53, 54) for rapid regulation of effector pathways (55,
56). For example, p38β appears to be involved in the reg-
ulation of N-type calcium currents by bradykinin in a
neuronal cell line, a response that occurs within seconds
(14). Additionally, in neutrophils, p38 is activated with-
in 2 minutes of exposure to formyl-methionyl-leucyl-
phenylalanine (fMLP), an inflammatory stimulus, and
modulates the response to hypertonic exposure (57).
These studies support roles for p38 MAP kinase in rapid
regulation of cellular events that are not necessarily
related to gene transcription.
Assuming that p38 functions as a primary signal gov-
erning Na+ influx and resting cell volume, several addi-
tional points merit further investigation. First, because
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the molecular identity of the NSC channel has not been
established, the cellular site(s) of action of p38 is not
clear. p38 may modulate channel activity by direct phos-
phorylation, or conversely, through effects on down-
stream kinases or phosphatases. Second, functional
interactions between p38 and other kinases are likely to
be operative. For example, preliminary evidence suggests
that tyrosine kinase activity is also important in the
response to cell volume changes (58, 59), and Src tyrosine
kinase has been shown to be a direct regulator of ion
channel function in different cell types (60). The
sequence of action and relative importance of p38 versus
other kinases has not been established, and is likely to be
cell-type specific. For example, it should be noted that
while PD98059 did not inhibit the response to hyper-
tonic exposure, a role of ERK in channel regulation
through MEK-1–independent pathways cannot be
excluded. Lastly, a broad range of physiologic and patho-
logic stimuli modulate NSC channel activity, though the
role of p38 in the mediation of these responses is largely
unknown. However, p38 has been shown to play an
important role in the insulin signaling pathway (61) as
well as in responses to oxidative stress (38) and the initi-
ation of apoptosis (62, 63), processes that are associated
with alterations in cell volume (20, 64).
Taken together, these findings indicate that in HTC
cells, p38 MAP kinase plays a key role in tonic inhibi-
tion of Na+ permeability and maintenance of cell vol-
ume. It is clear, however, that the inhibitory effects of
p38 MAP kinase are opposed by intracellular [Ca2+] and
presumably other stimulatory signals that work in con-
cert to modulate Na+ permeability in response to
changing physiologic demands. Definition of the com-
plex signaling pathways involved may provide new
strategies for modulating liver cell function through
effects on cell volume, and for minimizing cell injury
caused by sustained Na+ influx.
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